When we talk about innovation in health, we often think of new treatments or cutting-edge medical technologies. More accurate diagnoses, more effective treatments, faster recovery. These are certainly important elements. But Singapore's RIE2030 takes a much broader view of health.
In this document, health is not a research field—it is a matter of systems.
Why is this approach necessary? The reason is simple. Health is no longer just a medical issue but a matter of national finances and social structure. The trends of aging populations, chronic diseases, and rising medical costs are unavoidable in any country. As technology advances, treatments become more sophisticated, but costs increase even faster. Treatment-focused innovation alone cannot change this structure.
This phenomenon is evident in many countries. As new cancer treatments emerge, survival rates improve, but treatment costs also surge dramatically. Cases where a single patient's treatment costs range from tens of millions to hundreds of millions of won are common. Medical technology advances, but national healthcare finances face ever-greater burdens. This is why technological innovation does not necessarily mean systemic innovation.
RIE2030 reframes the question at this point.
It asks not which technology is superior, but which system can change both costs and quality of life simultaneously.
This is why Singapore focuses on what happens before treatment, not after. The structure aims to reduce the occurrence of diseases rather than responding after they develop. Prevention, early diagnosis, lifestyle management, and data-driven prediction emerge as key concepts for this reason.
Consider chronic diseases like diabetes and cardiovascular disease. In most countries, treatment begins only after patients visit hospitals. In Singapore, however, policies are being strengthened to identify and manage at-risk groups early by utilizing health checkup data and lifestyle data. By continuously tracking individuals' health status and connecting them with lifestyle management programs, the approach seeks to delay or reduce the onset of disease itself. Even within the same healthcare system, treatment-centered and prevention-centered structures create significant differences in long-term fiscal burden.
In this approach, the meaning of health data changes completely. Medical records transform from information confined within hospitals to assets for society as a whole. When individual health data accumulates under appropriate protection and trust frameworks, it becomes the basis for policy design and fiscal management. RIE2030 treats health not as a matter of technology but as a matter of data and trust.
For example, when health data accumulates over the long term, disease occurrence patterns can be predicted, and risk factors appearing in specific age groups or regions can be detected early. This affects not only hospital treatment costs but also labor productivity and social welfare policies. The moment medical data transcends simple clinical records and becomes the foundation for social policy, data becomes an asset rather than a cost.
This is where the logic of transformation economy reappears. Healthcare spending is traditionally a cost—the more it grows, the greater the burden. However, when the health system shifts toward prevention, the cost structure itself changes. Treatment costs decrease, productivity is maintained, and social assets accumulate. The same money produces entirely different results.
For instance, when early diagnosis programs expand, the likelihood of detecting cancer or cardiovascular disease at initial stages increases. Early treatment costs are relatively low, and recovery prospects are high. Conversely, when treatment begins after disease has progressed, costs multiply several times over. Depending on system design, the same medical technology produces entirely different economic outcomes.
Another element Singapore emphasizes in health is integration. Hospitals, research institutes, companies, and policy do not operate separately. RIE2030 binds them into a single system. Technology development is merely one element within it. The judgment is that technology cannot be effective unless the system changes.
For example, even if a health tech startup develops new diagnostic technology, it is difficult to deploy in actual clinical settings without connection to hospital systems, insurance frameworks, and data platforms. Conversely, when policy, hospitals, and industry move within a single ecosystem, technology can spread much faster. Singapore views this connective structure itself as the core of policy design.
This approach poses an unfamiliar question for Korea as well. When we talk about health innovation, we still ask which technologies are leading. But the more important question may be this: Is our health system designed to reduce costs, or is it moving in a direction that accumulates them?
Korea also possesses world-class medical technology and hospitals, but a significant portion of its healthcare system is designed around treatment. Unless prevention and lifestyle management data are sufficiently connected to policy, the healthcare system will inevitably continue moving toward a structure that expands treatment costs. It is not a matter of technology but a matter of systems.
RIE2030 does not view health merely as a growth industry. It sees it as a core system that determines society's sustainability. And it concludes that without transforming this system, no technology will be sufficient.
In the next installment, we will examine another important area following health: cities. In RIE2030, cities are not merely residential spaces but massive testbeds where policy and technology are experimented.
